Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Pharmacogenetics of 6-Mercaptopurine in a Black Zimbabwean Cohort Treated for Acute Lymphoblastic Leukaemia

Pharmacogenomics(2023)10.2217/pgs-2023-0026Source: DataRank Database

Pharmacogenetics of 6-Mercaptopurine in a Black Zimbabwean Cohort Treated for Acute Lymphoblastic Leukaemia is a research paper published in Pharmacogenomics (2023). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

refsnp

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.94)OA: greenTopics (36)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Derick Munkombwe ORCID,Zedias Chikwambi ORCID,Patience Kuona ORCID,Collen Masimirembwa ORCID,Pageneck Chikondowa ORCID

Live enrichment

PubMed:37248698 PMC:PMC10463210 OpenAlex:https://openalex.org/W4378746368

Bill and Melinda Gates Foundation (BMGF) grant

Grant: FY18.276.002, INV-036801

European & Developing Countries Clinical Trials Partnership grant

Grant: TMA2016SF-1508

National Institute of Health (NIH) Grant

Grant: 5P20CA210677

NCI NIH HHS

Grant: P20 CA210677

FWCI

0.94

Citation Percentile

0.7%

Influential Citations

Citation Trend

2025

2026

green

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10463210/pdf/pgs-24-449.pdf

GREENhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463210

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10463210/pdf/pgs-24-449.pdf

publisherhttps://www.tandfonline.com/doi/pdf/10.2217/pgs-2023-0026

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10463210

Fields of Study

Acute Lymphoblastic Leukemia researchRenal Transplantation Outcomes and TreatmentsChildhood Cancer Survivors' Quality of LifeMedicineHumansMercaptopurinePharmacogeneticsZimbabweAntimetabolites, AntineoplasticPrecursor Cell Lymphoblastic Leukemia-LymphomaMethyltransferasesPyrophosphatases

MeSH Terms

Antimetabolites, AntineoplasticHumansMethyltransferasesPharmacogeneticsPyrophosphatasesZimbabweMercaptopurinePrecursor Cell Lymphoblastic Leukemia-Lymphoma

Keywords

MercaptopurinePharmacogeneticsMedicineCohortPharmacologyPediatricsInternal medicineGeneticsGenotypeBiologyGene6-mercaptopurineZimbabweAcute Lymphoblastic LeukaemiaThiopurine MethyltransferaseTpmt

Sustainable Development Goals

SDG 0: Good health and well-being